Nuvation Bio, Inc. (NUVB)
6.76
-0.17
(-2.45%)
USD |
NYSE |
Aug 24, 16:00
6.76
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio Debt to Equity Ratio : 1.640 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.640 |
| March 31, 2026 | 0.679 |
| December 31, 2025 | 0.6959 |
| September 30, 2025 | 0.6387 |
| June 30, 2025 | 0.5454 |
| March 31, 2025 | 0.0272 |
| December 31, 2024 | 0.0192 |
| September 30, 2024 | 0.0223 |
| June 30, 2024 | 1.126 |
| March 31, 2024 | 0.0059 |
| December 31, 2023 | 0.0066 |
| September 30, 2023 | 0.0073 |
| June 30, 2023 | 0.0059 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0062 |
| December 31, 2022 | 0.0065 |
| September 30, 2022 | 0.0067 |
| June 30, 2022 | 0.0068 |
| March 31, 2022 | 0.0038 |
| December 31, 2021 | 0.0041 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 3.333 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Bristol Myers Squibb Co. | 2.019 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| EyePoint, Inc. | 0.1344 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 744.50M |
| Total Liabilities (Quarterly) | 490.64M |
| Shareholders Equity (Quarterly) | 253.86M |
| Current Ratio | 8.373 |
| Net Debt Paydown Yield | -4.08% |